SPRO
Spero Therapeutics Inc
$1.27
Earnings Summary
Revenue | $25.47Mn |
Net Profits | $-3.21Mn |
Net Profit Margins | -12.58% |
Highlights
Spero Therapeutics Inc’s revenue jumped 2254.25% since last year same period to $25.47Mn in the Q3 2023. On a quarterly growth basis, Spero Therapeutics Inc has generated 3132.61% jump in its revenue since last 3-months.
Spero Therapeutics Inc’s net profit jumped 72.17% since last year same period to $-3.21Mn in the Q3 2023. On a quarterly growth basis, Spero Therapeutics Inc has generated 73.1% jump in its net profits since last 3-months.
Spero Therapeutics Inc’s net profit margin jumped 98.82% since last year same period to -12.58% in the Q3 2023. On a quarterly growth basis, Spero Therapeutics Inc has generated 99.17% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Spero Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | 0.05 |
EPS Estimate Current Year | 0.05 |
Highlights
Spero Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.05 - a 266.67% jump from last quarter’s estimates.
Spero Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at 0.05.
Key Ratios
Key ratios of the Spero Therapeutics Inc post its Q3 2023 earnings
Earning Per Share (EPS) | 0.04 |
Highlights
Spero Therapeutics Inc’s earning per share (EPS) jumped 112.12% since last year same period to 0.04 in the Q3 2023. This indicates that the Spero Therapeutics Inc has generated 112.12% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-10 | -0.34 | -0.23 | 32.35% |
2023-05-11 | -0.33 | -0.25 | 24.24% |
2023-11-13 | -0.03 | 0.04 | 233.33% |
₹0 US Stocks a/c Opening Fee